Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.60 Insider Own1.10% Shs Outstand106.82M Perf Week5.21%
Market Cap1.25B Forward P/E- EPS next Y-1.03 Insider Trans-10.39% Shs Float95.54M Perf Month11.84%
Income-61.00M PEG- EPS next Q-0.21 Inst Own83.50% Short Float7.76% Perf Quarter-8.44%
Sales108.50M P/S11.53 EPS this Y35.80% Inst Trans-0.76% Short Ratio5.29 Perf Half Y-47.91%
Book/sh2.75 P/B4.26 EPS next Y-37.30% ROA-22.10% Target Price27.20 Perf Year-44.97%
Cash/sh2.06 P/C5.67 EPS next 5Y- ROE-30.60% 52W Range6.22 - 25.29 Perf YTD33.83%
Dividend- P/FCF- EPS past 5Y-19.40% ROI-10.50% 52W High-53.70% Beta2.75
Dividend %- Quick Ratio2.60 Sales past 5Y-13.70% Gross Margin71.20% 52W Low88.26% ATR0.53
Employees215 Current Ratio2.60 Sales Q/Q-30.50% Oper. Margin- RSI (14)57.48 Volatility3.85% 5.03%
OptionableYes Debt/Eq0.12 EPS Q/Q-194.50% Profit Margin-92.10% Rel Volume0.47 Prev Close11.70
ShortableYes LT Debt/Eq0.00 EarningsMar 05 AMC Payout- Avg Volume1.40M Price11.71
Recom1.60 SMA205.51% SMA508.85% SMA200-29.38% Volume661,988 Change0.09%
Nov-12-18Reiterated B. Riley FBR Buy $35 → $29
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Feb-07-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum on February 14 Business Wire
12:50AM  Top 4 Small-Cap Stocks for 2018 Investopedia
Jan-17-19 08:25AM  Spectrum Pharma Sells Marketed Portfolio in a Deal That Could Reach $300 Million TheStreet.com
07:56AM  Spectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone payments MarketWatch
07:45AM  Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients Business Wire
Jan-03-19 10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
Jan-02-19 07:00AM  Spectrum Pharmaceuticals Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations Business Wire +5.49%
Dec-28-18 09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-27-18 04:37PM  Why J.C. Penney, Tesla, and Spectrum Pharmaceuticals Slumped Today Motley Fool -6.53%
02:54PM  Here's Why Spectrum Pharmaceuticals Fell as Much as 13.1% Today Motley Fool
07:00AM  Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for ROLONTIS® (eflapegrastim) as a Treatment for Chemotherapy-Induced Neutropenia Business Wire
Dec-20-18 04:07PM  Here's Why Spectrum Pharmaceuticals, Inc. Is Getting Beaten Down Today Motley Fool -38.79%
10:52AM  Spectrum Pharma Shares Plunge As FDA Refuses Breakthrough Designation For Lung Cancer Drug Benzinga
07:53AM  The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum Benzinga
07:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and MannKind ACCESSWIRE
Dec-19-18 05:09PM  Stocks making the biggest moves after hours: Tilray, Spectrum Pharmaceuticals and more CNBC
04:28PM  Spectrum Pharma stock tanks after drug fails to get on speedier track MarketWatch
04:00PM  Spectrum Pharmaceuticals Provides Poziotinib Update Business Wire
Dec-18-18 10:43AM  Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): When Will It Breakeven? Simply Wall St.
Dec-12-18 11:41PM  Is Spectrum Pharmaceuticals, Inc. (SPPI) Going to Burn These Hedge Funds? Insider Monkey
Dec-10-18 09:00PM  Here's Why Spectrum Pharmaceuticals Rose 21.5% in November Motley Fool
Dec-08-18 09:30AM  Spectrum Pharma (SPPI) Down 3.7% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 04:18PM  Edited Transcript of SPPI earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
07:00AM  Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Annual Meeting Business Wire
Dec-03-18 08:25AM  Report: Exploring Fundamental Drivers Behind CVS Health, TransCanada, Nektar Therapeutics, LendingTree, Spectrum Pharmaceuticals, and TripAdvisor New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:00AM  Spectrum Pharmaceuticals Announces Positive Results from Phase 2 Trial Evaluating Use of Oral Leucovorin to Potentially Mitigate Mucositis in Patients Treated with FOLOTYN® (pralatrexate) Business Wire
Nov-30-18 07:00AM  Spectrum Pharmaceuticals Highlights Three Posters at the 60th Annual Meeting of the American Society of Hematology Business Wire
Nov-13-18 07:00AM  Spectrum Pharmaceuticals Appoints Dr. Jeffrey Vacirca to its Board of Directors Business Wire
Nov-09-18 08:01AM  Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3 Zacks
07:41AM  Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View Zacks
06:55AM  Today's Research Reports on Trending Tickers: Omeros and Spectrum Pharmaceuticals ACCESSWIRE
Nov-08-18 05:15PM  Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:08PM  Spectrum Pharma: 3Q Earnings Snapshot Associated Press
04:00PM  Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results Business Wire
Nov-07-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 London Healthcare Conference on November 14 Business Wire
Nov-01-18 07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2018 Financial Results Teleconference and Webcast Business Wire +6.97%
Oct-25-18 10:34AM  Spectrum Pharmaceuticals (SPPI) Q3 Earnings Preview: What's Shaping Up? Zacks +6.53%
Oct-24-18 09:20AM  Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -10.88%
Oct-23-18 07:00AM  Spectrum Pharmaceuticals Receives FDA Approval of KHAPZORY (levoleucovorin) for injection Business Wire +5.84%
Oct-19-18 08:28AM  The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut Benzinga
Oct-18-18 07:00AM  Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer Business Wire -6.30%
Oct-12-18 10:14AM  Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock Zacks
Oct-03-18 06:45PM  Top 4 Small-Cap Stocks for 2018 Investopedia
Sep-27-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2018 Cantor Global Healthcare Conference on October 2 Business Wire
Sep-24-18 11:40AM  Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients Business Wire -22.66%
Sep-13-18 01:35PM  Is Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) A Financially Strong Company? Simply Wall St.
09:13AM  Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study Zacks
Sep-12-18 07:00AM  Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient Business Wire -5.35%
Sep-07-18 08:57AM  Spectrum Pharmaceuticals (SPPI) Catches Eye: Stock Jumps 5.7% Zacks
Sep-06-18 08:28AM  The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data Benzinga +5.70%
08:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and NovoCure ACCESSWIRE
Sep-05-18 05:21PM  Spectrum Pharmaceuticals Announces Release of Poziotinib Abstract as Part of the IASLC 19th World Conference on Lung Cancer Business Wire
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-31-18 08:44AM  Implied Volatility Surging for Spectrum Pharmaceuticals (SPPI) Stock Options Zacks
08:15AM  Report: Exploring Fundamental Drivers Behind International Bancshares, Morgan Stanley, Equity Residential, Hormel Foods, Spectrum Pharmaceuticals, and Cousins Properties New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-30-18 07:00AM  Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September Business Wire -6.80%
Aug-28-18 09:00AM  AVANT DIAGNOSTICS ADDS TWO ESTEEMED, INTERNATIONALLY RECOGNIZED BOARD MEMBERS AND FILES ITS 2016 10-K IN PREPARATION OF GETTING CURRENT WITH THE SEC GlobeNewswire
Aug-24-18 11:45PM  Edited Transcript of SPPI earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-18 08:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Alnylam Pharmaceuticals ACCESSWIRE
Aug-10-18 12:31PM  Why Spectrum Pharmaceuticals Inc. Is Up Big on Mixed Earnings Motley Fool +10.67%
09:35AM  Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2 Zacks
Aug-09-18 05:20PM  Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:19PM  Spectrum Pharma: 2Q Earnings Snapshot Associated Press
04:00PM  Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update Business Wire
Aug-02-18 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2018 Financial Results Teleconference and Webcast Business Wire
Jul-27-18 08:00AM  New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-23-18 07:05AM  Complimentary Technical Snapshots on Sorrento Therapeutics and Three More Biotech Stocks ACCESSWIRE
Jun-29-18 07:00AM  Spectrum Pharmaceuticals Presents ADVANCE Phase 3 ROLONTIS® (eflapegrastim) Data at MASCC 2018 and Announces the Phase 3 RECOVER Study Met the Primary Endpoint Business Wire
Jun-27-18 12:03PM  Harry Boxers four momentum stocks breaking out MarketWatch
08:00AM  Todays Research Reports on Stocks to Watch: Spectrum Pharmaceuticals and Sophiris ACCESSWIRE
Jun-26-18 10:36AM  Here's Why Spectrum Pharmaceuticals Inc. Is Soaring Motley Fool +14.59%
09:31AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:15AM  Complimentary Technical Snapshots on Sorrento Therapeutics and Three More Biotech Stocks ACCESSWIRE
04:24AM  Spectrum Pharma Is Weighing a Sale Bloomberg
Jun-25-18 07:00AM  Spectrum Pharmaceuticals to Host Conference Call Highlighting ROLONTIS® (eflapegrastim) Phase 3 ADVANCE Study Data Presented at Multinational Association of Supportive Care in Cancer (MASCC) Business Wire
Jun-19-18 06:34AM  Spectrum Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
Jun-18-18 09:01PM  Why Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) Is A Financially Healthy Company Simply Wall St.
Jun-07-18 08:20AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Tesaro ACCESSWIRE
May-30-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 Global Healthcare Conference on June 6th Business Wire
May-25-18 07:10AM  Free Research Reports on Sorrento Therapeutics and Three More Biotech Stocks ACCESSWIRE
May-17-18 01:17PM  Why Spectrum Pharmaceuticals, Inc. Is Up Big Today Motley Fool +12.11%
02:10AM  CORRECTING and REPLACING Spectrum Pharmaceuticals Announces Detailed Results from Phase 3 Study of ROLONTIS® (eflapegrastim) Published in an ASCO Abstract Business Wire
May-16-18 05:20PM  Spectrum Pharmaceuticals Announces Detailed Results from Phase 3 Study of ROLONTIS® (eflapegrastim) Published in an ASCO Abstract Business Wire
May-09-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16th Business Wire
03:58AM  Edited Transcript of SPPI earnings conference call or presentation 3-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-07-18 07:10AM  Blog Exposure - Spectrum Pharma Inked Licensing Agreement with The University of Texas MD Anderson Cancer Center on Certain Methods of Use of Poziotinib ACCESSWIRE
May-04-18 11:31AM  Spectrum (SPPI) Earnings and Sales Beat Estimates in Q1 Zacks
May-03-18 05:06PM  Spectrum Pharma: 1Q Earnings Snapshot Associated Press
04:00PM  Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update Business Wire
07:00AM  Spectrum Pharmaceuticals Announces Exclusive Licensing Agreement on Certain Methods of Use of Poziotinib with The University of Texas MD Anderson Cancer Center Business Wire
May-01-18 07:00AM  Spectrum Pharmaceuticals Enters into a Next-Generation Sequencing Companion Diagnostic Partnership with Thermo Fisher Scientific Business Wire
Apr-30-18 04:47PM  Can These Top-Performing Biotech Stocks Keep Climbing? Motley Fool
07:00AM  Spectrum Pharmaceuticals Announces Corporate Governance Enhancements and Board Changes Business Wire
Apr-27-18 10:40AM  Company Profile for SPECTRUM PHARMACEUTICALS Business Wire
Apr-26-18 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2018 Financial Results Teleconference and Webcast Business Wire
Apr-23-18 11:25AM  Spectrum Pharmaceuticals Announces Publication of Poziotinib Data in Nature Medicine Business Wire
Apr-17-18 02:03PM  Spectrum Pharmaceuticals Highlights Data Showing Poziotinib Overcomes De Novo Resistance of HER2 Exon 20 Insertion Mutations in NSCLC and Other Cancers at the American Association for Cancer Research (AACR) in Chicago Business Wire +7.17%
06:56AM  Heres What Happened Last Week In Biotech Market Exclusive
Apr-14-18 07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Apr-12-18 07:00AM  Wired News Spectrum Pharma Reported Update Data from MD Andersons Phase-2 Data Assessing Poziotinib in EGFR Exon 20 Mutant NSCLC Patients ACCESSWIRE
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with B-cell non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast and lung cancer; ROLONTIS for chemotherapy-induced neutropenia; and QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. The company sells its drugs through group purchasing organizations, wholesalers, and directly in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGahan Keith MSVP and Chief Legal OfficerFeb 07Sale11.032,49627,541103,577Feb 08 05:28 PM
MAIDA ANTHONY E IIIDirectorJan 24Option Exercise4.817,25034,86138,688Jan 25 09:27 PM
MAIDA ANTHONY E IIIDirectorJan 24Sale10.377,25075,18332,988Jan 25 09:27 PM
Vyas DolatraiDirectorJan 22Sale10.626,01063,82641,069Jan 24 08:05 PM
Turgeon Joseph W.CEO & PresidentJan 16Sale10.445,09153,135408,541Jan 18 06:02 PM
Riga Thomas JEVP, COO & CCOJan 16Sale10.4410,499109,578231,083Jan 18 06:02 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 16Sale10.443,20733,471216,896Jan 18 05:59 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 11Sale10.8733,692366,333220,103Jan 11 06:27 PM
Turgeon Joseph W.CEO & PresidentJan 11Sale10.8736,311394,810413,632Jan 11 06:44 PM
MAIDA ANTHONY E IIIDirectorJan 07Option Exercise3.927,25028,42040,238Jan 08 05:56 PM
MAIDA ANTHONY E IIIDirectorJan 07Sale10.007,25072,50032,988Jan 08 05:56 PM
MAIDA ANTHONY E IIIDirectorDec 06Option Exercise3.927,25028,42040,238Dec 07 05:26 PM
MAIDA ANTHONY E IIIDirectorDec 06Sale12.607,25091,35032,988Dec 07 05:26 PM
MAIDA ANTHONY E IIIDirectorNov 08Option Exercise3.927,25028,42040,238Nov 09 06:50 PM
MAIDA ANTHONY E IIIDirectorNov 08Sale13.077,25094,75832,988Nov 09 06:50 PM
Gagnon GillesDirectorOct 09Sale15.3310,000153,34972,500Oct 11 08:06 PM
McGahan Keith MSVP and Chief Legal OfficerAug 08Sale20.964379,160105,993Aug 09 05:00 PM
Riga Thomas JEVP, COO & CCOJun 25Sale18.762354,408240,263Jun 26 01:31 PM
LENAZ LUIGI MDDirectorMay 22Option Exercise1.4740,00058,800109,077May 22 04:52 PM
SHROTRIYA RAJESH C MDDirectorMay 17Option Exercise1.46362,926529,001563,578May 17 06:38 PM
Krassner Stuart MitchellDirectorMay 17Sale18.9421,113399,88057,944May 18 05:26 PM
Riga Thomas JEVP, COO & CCOMay 14Sale18.103,29059,552240,498May 14 04:17 PM
SHROTRIYA RAJESH C MDDirectorMay 14Sale18.3824,014441,377615,963May 14 03:59 PM
COHEN RAYMOND WDirectorMay 14Sale18.329,275169,91828,850May 15 07:03 PM
SHROTRIYA RAJESH C MDDirectorMay 11Sale17.5530,000526,500639,977May 14 03:59 PM
SHROTRIYA RAJESH C MDDirectorMay 10Sale17.1330,000513,900669,977May 14 03:59 PM
SHROTRIYA RAJESH C MDDirectorMay 09Sale16.2130,000486,300699,977May 09 04:02 PM
SHROTRIYA RAJESH C MDDirectorMay 08Sale16.1130,000483,300729,977May 09 04:02 PM
SHROTRIYA RAJESH C MDDirectorMay 07Sale15.9830,000479,400759,977May 09 04:02 PM
SHROTRIYA RAJESH C MDDirectorMay 04Sale16.7930,000503,700789,977May 04 03:37 PM
SHROTRIYA RAJESH C MDDirectorMay 03Sale16.0130,000480,300819,977May 04 03:37 PM
SHROTRIYA RAJESH C MDDirectorMay 02Sale16.0430,000481,200849,977May 04 03:37 PM
SHROTRIYA RAJESH C MDDirectorMay 01Sale15.7730,000473,100879,977May 01 05:55 PM
SHROTRIYA RAJESH C MDDirectorApr 30Sale16.3630,000490,800909,977May 01 05:55 PM
SHROTRIYA RAJESH C MDDirectorApr 27Sale17.1730,000515,100939,977May 01 05:55 PM
SHROTRIYA RAJESH C MDDirectorApr 26Sale17.2630,000517,800969,977Apr 26 06:39 PM
SHROTRIYA RAJESH C MDDirectorApr 25Sale17.2630,000517,800999,977Apr 26 06:39 PM
SHROTRIYA RAJESH C MDDirectorApr 24Sale18.1130,000543,3001,029,977Apr 26 06:39 PM
SHROTRIYA RAJESH C MDDirectorApr 23Sale18.3730,000551,1001,059,977Apr 23 09:53 PM
SHROTRIYA RAJESH C MDDirectorApr 20Sale18.6730,000560,1001,089,977Apr 23 09:53 PM
SHROTRIYA RAJESH C MDDirectorApr 19Sale19.1830,000575,4001,119,977Apr 23 09:53 PM
SHROTRIYA RAJESH C MDDirectorApr 18Sale19.7130,000591,3001,149,977Apr 18 04:38 PM
Turgeon Joseph W.CEO & PresidentApr 17Sale19.0011,565219,751316,509Apr 18 04:40 PM
SHROTRIYA RAJESH C MDDirectorApr 17Sale18.5630,000556,8001,179,977Apr 18 04:38 PM
Riga Thomas JEVP, COO & CCOApr 17Sale19.071,84035,083243,854Apr 17 07:04 PM
SHROTRIYA RAJESH C MDDirectorApr 16Sale18.7230,000561,6001,209,977Apr 18 04:38 PM
Riga Thomas JEVP, COO & CCOApr 16Sale18.603,90072,521254,694Apr 17 07:04 PM
SHROTRIYA RAJESH C MDDirectorApr 13Sale19.9330,000597,9001,239,977Apr 13 05:07 PM
SHROTRIYA RAJESH C MDDirectorApr 12Sale20.7230,000621,6001,269,977Apr 13 05:07 PM
SHROTRIYA RAJESH C MDDirectorApr 11Sale20.3030,000609,0001,299,977Apr 13 05:07 PM
SHROTRIYA RAJESH C MDDirectorApr 10Sale17.7430,000532,2001,329,977Apr 10 08:41 PM
SHROTRIYA RAJESH C MDDirectorApr 09Sale15.0112,300184,6231,359,977Apr 10 08:41 PM
SHROTRIYA RAJESH C MDDirectorApr 06Sale15.003,68655,2901,372,277Apr 10 08:41 PM
SHROTRIYA RAJESH C MDDirectorApr 05Sale15.3330,000459,9001,375,963Apr 05 04:00 PM
SHROTRIYA RAJESH C MDDirectorApr 04Sale15.0130,000450,3001,405,963Apr 05 04:00 PM
SHROTRIYA RAJESH C MDDirectorApr 03Sale15.1430,000454,2001,435,963Apr 05 04:00 PM
SHROTRIYA RAJESH C MDDirectorApr 02Sale15.6130,000468,3001,465,963Apr 02 05:43 PM
Riga Thomas JChief Operating OfficerApr 02Sale15.581,94830,350256,452Apr 02 05:30 PM
SHROTRIYA RAJESH C MDDirectorMar 29Sale16.1830,000485,4001,495,963Apr 02 05:43 PM
Turgeon Joseph W.CEO & PresidentMar 28Sale16.404,81078,884328,074Mar 28 05:12 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 28Sale16.354,35071,123187,193Mar 28 05:05 PM
SHROTRIYA RAJESH C MDDirectorMar 28Sale16.1930,000485,7001,525,963Mar 28 04:38 PM
SHROTRIYA RAJESH C MDDirectorMar 27Sale17.1030,000513,0001,555,963Mar 28 04:38 PM
SHROTRIYA RAJESH C MDDirectorMar 26Sale17.3430,000520,2001,585,963Mar 28 04:38 PM
Riga Thomas JChief Operating OfficerMar 26Sale17.412203,830251,476Mar 27 06:45 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 26Sale17.381,30022,594191,543Mar 27 06:33 PM
Turgeon Joseph W.CEO & PresidentMar 22Sale18.173,10056,327332,884Mar 23 06:43 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 22Sale18.132,64047,868192,843Mar 23 06:36 PM
Krassner Stuart MitchellDirectorMar 21Option Exercise2.5530,00076,50083,257Mar 23 06:46 PM
Krassner Stuart MitchellDirectorMar 21Sale18.644,20078,27879,057Mar 23 06:46 PM
SHROTRIYA RAJESH C MDDirectorMar 09Option Exercise2.55500,0001,275,0001,787,542Mar 12 06:05 PM
open in yahoo | open in reuters | open in google